Ferran Sanz is chemical engineer by the Institut Quimic de Sarrià (Barcelona) and BSc and PhD by the Universitat Autònoma de Barcelona. He is Professor of Biostatistics and Biomedical Informatics at Universitat Pompeu Fabra (UPF), scientific staff of the Hospital del Mar Medical Research Institute (IMIM) and Director of the IMIM-UPF Research Programme on Biomedical Informatics (GRIB). He is also visiting professor at Naples, Düsseldorf and Vienna Universities.
Author of more than 130 articles in ISI-indexed journals. Mentor of 18 PhD thesis. He led nine EU-funded initiatives from the 4th Framework Programme, as well as a STOA report for the European Parliament. Currently, he is coordinating the H2020 project MedBioinformatics on the translational and clinical application of bioinformatics and is the academic coordinator of the IMI project eTOX on the in silico prediction of drug toxicity. Partner in other ongoing EU-funded projects: EMIF, EUToxRisk, iPiE, Elixir-Excelerate and transQST. Academic coordinator of the Plataforma Tecnológica Española de Medicamentos Innovadores (PTEMI). Coordinator of the Biomedical Informatics Node of the Spanish Institute of Bioinformatics (INB). Vicepresident of the Bioinformatics Barcelona Association (BIB). President of the European Federation for Medicinal Chemistry (EFMC) from January 2003 to December 2005. Vice-rector for Scientific Policy of the UPF from January 2004 to March 2009. Member of the Scientific Committee of IMI until 2013.
Computational approaches in drug discovery and development with a particular focus on the prediction of potential adverse drug reactions.
Integrative knowledge management and exploitation in biomedicine, including multi-level and multi-scale modelling and simulation.